The incidence of Hepatitis B in France has been forecasted to remain constant at 100 cases per hundred persons from 2024 to 2028. This stability suggests no significant year-on-year changes from the current data, as the incidence rate was also 100 cases per hundred persons in 2023. Consequently, the Compound Annual Growth Rate (CAGR) over the five-year period remains 0%, reflecting a steady situation.
Future trends to watch for include potential advancements in vaccination campaigns or public health strategies that could lead to a decline in incidence. Monitoring changes in healthcare policy and public awareness initiatives will be crucial in understanding potential shifts in these metrics. Additionally, observing any emerging strains or variations in Hepatitis B due to global mobility and public health challenges will be important for future forecasts.
